XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
May 03, 2025
May 04, 2024
Income Statement [Abstract]    
Net sales $ 473,973 [1] $ 457,597 [2]
Cost of sales 252,792 241,316
Gross margin 221,181 216,281
Selling and administrative expenses 249,035 247,831
Asset impairments and other, net 291 [3] 578 [4]
Operating loss (28,145) (32,128)
Other components of net periodic benefit cost 180 109
Interest expense, net 1,339 890
Loss from continuing operations before income taxes (29,664) (33,127)
Income tax benefit (8,452) (8,839)
Loss from continuing operations (21,212) (24,288)
Loss from discontinued operations, net of tax (15) (59)
Net Loss $ (21,227) $ (24,347)
Basic loss per common share:    
Continuing operations (in dollars per share) $ (2.02) $ (2.22)
Discontinued operations (in dollars per share) 0 (0.01)
Net loss (in dollars per share) (2.02) (2.23)
Diluted loss per common share:    
Continuing operations (in dollars per share) (2.02) (2.22)
Discontinued operations (in dollars per share) 0 (0.01)
Net loss (in dollars per share) $ (2.02) $ (2.23)
Weighted average shares outstanding:    
Basic (in shares) 10,495 10,930
Diluted (in shares) 10,495 10,930
[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the first quarter of Fiscal 2026
[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales for the first quarter of Fiscal 2025
[3] Asset impairments and other includes a $0.3 million charge for severance.
[4] Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance.